All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD(+) leukemia stem cells in vitro and in vivo

FMS-like tyrosine kinase 3 (FLT3)-mutant acute myeloid leukemia (AML) portends a poor prognosis, and ineffective targeting of the leukemic stem cell (LSC) population remains one of several obstacles in treating this disease. All-trans retinoic acid (ATRA) has been used in several clinical trials for...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood
Glavni autori: Ma, Hayley S., Greenblatt, Sarah M., Shirley, Courtney M., Duffield, Amy S., Bruner, J. Kyle, Li, Li, Nguyen, Bao, Jung, Eric, Aplan, Peter D., Ghiaur, Gabriel, Jones, Richard J., Small, Donald
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2016
Teme:
Myeloid Neoplasia
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4900954/
https://ncbi.nlm.nih.gov/pubmed/27103744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-05-646786
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items